Published Jan 6, 2023

Science Vs Snakes

Delve into the intricate world of snake venom with Roman Mars and Wendy Zukerman as they unravel the complexities of venom composition, challenge stereotypes around snake behavior, and examine groundbreaking advancements in antivenom production, offering hope for more effective and universal treatments.
Episode Highlights
99% Invisible logo

Popular Clips

Episode Highlights

  • Traditional Methods

    The traditional method of producing antivenom has remained largely unchanged for over a century. explains that the process begins with extracting venom from snakes, which is then injected into horses to produce antibodies. These antibodies are harvested and used to create antivenom, a method that has been in place since the late 1800s 1. Despite its effectiveness, the process is complex and labor-intensive, requiring the use of multiple animals and facilities worldwide 2. questions why this outdated method persists, to which Wendy responds that the dream is to develop a universal antivenom that could simplify and expedite treatment 2.

       

    Scientific Breakthroughs

    Recent scientific advancements are paving the way for innovative approaches to antivenom production. highlights that since 2017, increased attention and funding have led to breakthroughs in understanding snake venom and developing universal antivenoms 3. Researchers are now focusing on targeting families of toxins rather than individual ones, which simplifies the process and enhances effectiveness 4. notes that this approach is akin to developing a defense strategy against the most dangerous players in a game, rather than each player individually 4.

       

    Novel Approaches

    Novel approaches in antivenom research are showing promise, with scientists exploring drug-based solutions instead of relying solely on animal-derived antibodies. discusses a promising clinical trial involving a drug that interferes with zinc, a crucial element for certain venom enzymes 5. This method, while still in early stages, could complement existing antivenoms and provide quicker, more accessible treatments. draws parallels to the rapid development of COVID-19 vaccines, suggesting that with sufficient funding and global collaboration, significant progress can be achieved in antivenom research 5.

Related Episodes